Palbociclib and hormonal therapy may extend survival in advanced breast cancer patients

22 Oct 2018


The drug palbociclib when combined with hormonal therapy extends the survival of patients with advanced breast cancer, according to research published in the New England Journal of Medicine.

The Guardian


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story